Correction to: Diabetes, cardiovascular disease and the microcirculation

W David Strain¹, P M Paldánius^{2

3}

Affiliations

¹ Diabetes and Vascular Research Centre, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK. d.strain@exeter.ac.uk.
² Novartis Pharma AG, Basel, Switzerland.
³ Research Group for Clinical and Molecular Metabolism (CAMM), Children's Hospital, Helsinki University Hospital (HUS), Helsinki University, Helsinki, Finland.

Published Erratum

W David Strain et al. Cardiovasc Diabetol. 2021.

. 2021 Jun 11;20(1):120.

doi: 10.1186/s12933-021-01307-5.

W David Strain¹, P M Paldánius^{2

3}

¹ Diabetes and Vascular Research Centre, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK. d.strain@exeter.ac.uk.
² Novartis Pharma AG, Basel, Switzerland.
³ Research Group for Clinical and Molecular Metabolism (CAMM), Children's Hospital, Helsinki University Hospital (HUS), Helsinki University, Helsinki, Finland.

No abstract available

Erratum for

Diabetes, cardiovascular disease and the microcirculation.
Strain WD, Paldánius PM. Strain WD, et al. Cardiovasc Diabetol. 2018 Apr 18;17(1):57. doi: 10.1186/s12933-018-0703-2. Cardiovasc Diabetol. 2018. PMID: 29669543 Free PMC article. Review.

1. Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17:57. doi: 10.1186/s12933-018-0703-2. - DOI - PMC - PubMed
1. Kim KM, Jung KY, Yun HM, Lee SY, Oh TJ, Jang HC, Lim S. Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovasc Diabetol. 2017;16(1):146. doi: 10.1186/s12933-017-0629-0. - DOI - PMC - PubMed